Global Levofloxacin Market Size study & Forecast, by Application (Pneumonia, Skin Infection, Kidney Infection, Bladder Infection, Other Applications), and Regional Analysis, 2022-2029

Global Levofloxacin Market Size study & Forecast, by Application (Pneumonia, Skin Infection, Kidney Infection, Bladder Infection, Other Applications), and Regional Analysis, 2022-2029

Global Levofloxacin Market is valued at approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than 5.1% over the forecast period 2022-2029. Levofloxacin is an antibiotic used to kill germs within the body that is sold under the trade name Levaquin. Levofloxacin and other fluoroquinolone antimicrobials block DNA gyrase and topoisomerase IV in bacteria as part of their mechanism of action. It is offered as a tablet and as an injectable medication. This medication is used to diagnose several illnesses, including acute bacterial sinusitis, chronic prostatitis, urinary tract infections, and pneumonia. The market growth is driven by the growing Incidence of Bacterial Infections and the rising number of Baby Boomers are the key factors responsible for the market growth.

The World Health Organization's Global Tuberculosis Report 2021 states that in October 2021, South-East Asia (43%), Africa (25%), and the Western Pacific (18%) had the highest numbers of tuberculosis cases, while the Eastern Mediterranean (8.3%), Americas (3.0%), and Europe (2.3% had the lowest percentages. Statistics show that the prevalence of tuberculosis is high worldwide, which is considered to boost market expansion because Levofloxacin is frequently used to treat the disease. However, a lack of Awareness Associated with Infectious diseases stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Levofloxacin Market study includes Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is dominating the worldwide revenue owing to technological advancements and the increasing prevalence of chronic diseases. However, Asia Pacific is expected to be the fastest-growing region in the forecast years due to major expansion in manufacturing pharmacies.

Major market players included in this report are:
Dr. Reddy's Laboratories Ltd
Aden Healthcare
Alna Biotech Private Limited
Divine Savior Pvt LtdAllenge India Pharma
Glenmark Pharmaceuticals Limited
Zydus Cadila
Lupin Limited
Bestochem
PAX Healthcare

Recent Developments in the Market:
 In February 2022, the Indian pharmaceutical conglomerate Dr. Reddy's Laboratories and Binnopharm Group, a major Russian drug producer through its affiliate Alium, announced the signing of an agreement that will allow Binnopharm Group to purchase antibacterial drugs from Dr. Reddy's in Russia, Uzbekistan, and Belarus under the Ciprolet (ciprofloxacin) and Levolet (levofloxacin) brands.
 NTC and Aspen will report SAHPRA-satisfactory results for the fixed-dose combination of levofloxacin and dexamethasone multidose eye in November 2021.

Global Levofloxacin Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Application, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study.

The report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:
By Application:
Pneumonia
Skin Infection
Kidney Infection
Bladder Infection
Other Applications

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Companies Mentioned

Dr. Reddy's Laboratories Ltd
Aden Healthcare
Alna Biotech Private Limited
Divine Savior Pvt LtdAllenge India Pharma
Glenmark Pharmaceuticals Limited
Zydus Cadila
Lupin Limited
Bestochem
PAX Healthcare

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.